solution

(redirected from ophthalmic solution)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

solution

(Answer), noun clarification, decipherment, determination, eludication, explanation, explicatio, exposition, finding, illumination, interpretation, key, reason, resolution, right answer, solutio
Associated concepts: equitable solution

solution

(Substance), noun admixture, amalgam, blend, combination, commixture, composite, composition, compound, dilutum, emulsion, intermixture, mix, mixture, solvent, suspension

SOLUTION, civil law. Payment.
2. By this term, is understood, every species of discharge or liberation, which is called satisfaction, and with which the creditor is satisfied. Dig. 46, 3, 54; Code 8, 43, 17; Inst. 3, 30. This term has rather a reference to the substance of the obligation, than to the numeration or counting of the money. Dig. 50, 16, 176. Vide Discharge of a contract.

References in periodicals archive ?

Bausch + Lomb licensed the Lumify brimonidine tartrate ophthalmic solution 0.

Bausch + Lomb Adds Vyzulta, Lumify

0 m market, and Diclofenac Sodium Ophthalmic Solution 0.

Aceto Subsidiary Acquires Three Ophthalmic ANDAs from Nexus Pharmaceuticals

The trial results suggest that both LUMIGAN(TM) ophthalmic solution and Xalatan(R) are safe and well tolerated by patients.

STUDY SHOWS LUMIGAN MORE EFFECTIVE THAN XALATAN

RESCULA([R]) ophthalmic solution has a history of showing notable activities of neuroprotection from the basic researches, and increase ocular circulation from the clinical studies.

R-Tech Ueno: Announcement of Approval of sNDA for RESCULA[R] Ophthalmic Solution and Start of Commercialization

Garamycin Ophthalmic Solution, a broad spectrum anti-infective, is indicated for the treatment of ocular bacterial infections such as conjunctivitis, keratitis and blepharitis.

Garamycin[R] Ophthalmic Solution Now Available from Fera Pharmaceuticals

05% for dry eye and expects to begin receiving royalties in 2011 based on net sales of DIQUAS[TM] Ophthalmic Solution 3% (diquafosol tetrasodium) for dry eye.

Inspire Announces Webcast of Presentation at Cowen Health Care Conference

10531 tropicamide + phenylephrine hydrochloride ophthalmic solution 0.

C.10531 tropicamide + phenylephrine hydrochloride ophthalmic solution 0.5% tropicamide phenylephrine + 5% 5ml dropper bottle

Human health company ACETO Corporation (NasdaqGS:ACET) reported on Tuesday that it has completed the acquisition of three ANDAs for the products Ciprofloxacin Ophthalmic Solution 3%, Levofloxacin Ophthalmic Solution 0.

ACETO subsidiary buys three US FDA approved ophthalmic ANDAs

Contract awarded for ketotifen fumarate ophthalmic solution 0.

Ketotifen fumarate ophthalmic solution 0.05%, 5 ml dropper bottle, bases ** ** see accompanying

M2 EQUITYBITES-August 27, 2015-Santen Pharmaceutical receives TAPROS Ophthalmic Solution import drug licence

Santen Pharmaceutical receives TAPROS Ophthalmic Solution import drug licence

M2 PHARMA-August 27, 2015-Santen Pharmaceutical receives TAPROS Ophthalmic Solution import drug licence

Santen Pharmaceutical receives TAPROS Ophthalmic Solution import drug licence

05% for dry eye and DIQUAS[TM] Ophthalmic Solution 3% (diquafosol tetrasodium) for dry eye.

Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results and Provide Corporate Update